In the past 52-week period, shares of Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) have moved within the range of $9.30 to $18.75. On the stock’s most recent trading day, the company’s shares ended the regular session at $18.40, which is 1.87% lower than its 52-week high.
Sucampo Pharmaceuticals, Inc. (SCMP) has demonstrated a 20-day simple moving average (SMA) of 5.08%, and a 50-day SMA of 32.14%. This public company’s current market capitalization stands at $862.96 million.Analyzing Consensus Estimates, Sales Revenue and Net Income
Gauging the level of enthusiasm that Wall Street analysts have for a particular stock is important when considering an investment. According to the latest data, the consensus recommendation for Sucampo Pharmaceuticals, Inc. (SCMP) is Hold.
When it comes to reporting sales figures, public companies typically post earnings and revenue that fall above or below the average Wall Street forecast. In the most recent quarterly financial report, for the quarter ending Sep. 2017, Sucampo Pharmaceuticals, Inc. (SCMP) delivered a 5.54% surprise with its net revenue. Sales reached $0.06 billion during the three-month period, compared to the average analyst estimate of $0.06 billion.
Meanwhile, during the same quarter Sucampo Pharmaceuticals, Inc. (SCMP) delivered a 6.30% earnings surprise. Net earnings for the quarter were posted at $0.27 per share, whereas Wall Street had forecast $0.25 per share.Ownership at Sucampo Pharmaceuticals, Inc. (SCMP), According to Most Recent SEC Filings
A publicly-traded company’s most recent 13F filings give us important details about the organization’s institutional ownership. Sucampo Pharmaceuticals, Inc. (SCMP) has 0 billion shares outstanding currently, 64.96% of which belong to institutional investors. Those institutional holdings amount to $0.57 billion.
Additionally, according to the most recent 13F filing from Sucampo Pharmaceuticals, Inc. (SCMP), there were 31 new positions totaling 3,519,066 shares of the company’s stock. There were 13 sold out positions, on the other hand, totaling 236,629 shares.Short, Medium and Long Term Indicators
Taking a look at a stock’s average volume – in the long, medium and short terms – is helpful for understanding investor sentiment and trading activity. Sucampo Pharmaceuticals, Inc. (SCMP) has had a 20-day average volume of 4,456,625 shares, with an average of 80% of short term indicators pointed at Buy.
The stock’s 50-day average volume has been 2,732,418 shares, with an average of 75% of medium term indicators pointing toward Buy. Finally, its 100-day average volume is 1,626,718 shares with 100% of long-term indicators pointing to Buy.